Venous thromboembolism risk in mastectomy and immediate breast reconstruction: Analysis of the 2005 to 2011 american college of surgeons national surgical quality improvement program data sets

Plastic and Reconstructive Surgery

Volumn 133, Issue 3, 2014, Pages

  Fischer, John P ^a   Wes, Ari M ^b   Tuggle, Charles T ^b   Wu, Liza C ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST RECONSTRUCTION; BREAST TUMOR; FACTUAL DATABASE; FEMALE; HUMAN; LUNG EMBOLISM; MASTECTOMY; METHODOLOGY; MIDDLE AGED; OBESITY; RISK FACTOR; TIME; UNITED STATES; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

BREAST NEOPLASMS; DATABASES, FACTUAL; FEMALE; HUMANS; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; OBESITY; PULMONARY EMBOLISM; RISK FACTORS; TIME FACTORS; UNITED STATES; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84897783773     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000438062.53914.22     Document Type: Article

References (36)

1. Davison SP, Venturi ML, Attinger CE, Baker SB, Spear SL. Prevention of venous thromboembolism in the plastic surgery patient. Plast Reconstr Surg. 2004;114:43E-51E.
2. Pannucci CJ, Oppenheimer AJ, Wilkins EG. Practice patterns in venous thromboembolism prophylaxis: A survey of 606 reconstructive breast surgeons. Ann Plast Surg. 2010;64:732-737.
3. Pannucci CJ, Wachtman CF, Dreszer G, et al. The effect of postoperative enoxaparin on risk for reoperative hematoma. Plast Reconstr Surg. 2012;129:160-168.
4. Pannucci CJ, Dreszer G, Wachtman CF, et al. Postoperative enoxaparin prevents symptomatic venous thromboembo-lism in high-risk plastic surgery patients. Plast Reconstr Surg. 2011;128:1093-1103.
5. Miszkiewicz K, Perreault I, Landes G, et al. Venous throm-boembolism in plastic surgery: Incidence, current practice and recommendations. J Plast Reconstr Aesthet Surg. 2009;62:580-588.
6. Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. Breast reconstruction: Increasing implant rates. Plast Reconstr Surg. 2013;131:15-23.
7. American College of Surgeons. American College of Surgeons National Surgical Quality Improvement Program. Available at: http://site.acsnsqip.org/ participant-usedata-fle/. Accessed December 1, 2012.
8. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22:39-47.
9. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med. 2000;160:809-815.
10. Lee AY. Thrombosis and cancer: The role of screening for occult cancer and recognizing the underlying biological mechanisms. Hematology Am Soc Hematol Educ Program 2006:438-443.
11. Leonardi MJ, McGory ML, Ko CY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: A systematic review of 33 randomized controlled trials. Arch Surg. 2006;141:790-797; discussion 797.
12. Lapid O, Pietersen L, van der Horst CM. Reoperation for haematoma after breast reduction with preopera-tive administration of low-molecular-weight heparin: Experience in 720 patients. J Plast Reconstr Aesthet Surg. 2012;65:1513-1517.
13. Kakkar AK, Haas S, Wolf H, Encke A. Evaluation of periop-erative fatal pulmonary embolism and death in cancer surgical patients: The MC-4 cancer substudy. Thromb Haemost. 2005;94:867-871.
14. Leonardi MJ, McGory ML, Ko CY. A systematic review of deep venous thrombosis prophylaxis in cancer patients: Implications for improving quality. Ann Surg Oncol. 2007;14:929-936.
15. Khorgami Z, Mofd R, Soroush A, Aminian A, Hosseini Araghi N, Hanaf S. Factors associated with inappropriate chemical prophylaxis of thromboembolism in surgical patients. Clin Appl Thromb Hemost. (in press).
16. Cameron IC, Azmy IA. Thromboprophylaxis in patients undergoing surgery for breast cancer. Breast 2001;10:535-537.
17. Pannucci CJ, Shanks A, Moote MJ, et al. Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery. Ann Surg. 2012;255:1093-1099.
18. Young VL, Watson ME. The need for venous thromboem-bolism (VTE) prophylaxis in plastic surgery. Aesthet Surg J. 2006;26:157-175.
19. Mahmoodi BK, Gansevoort RT, Naess IA, et al. Association of mild to moderate chronic kidney disease with venous throm-boembolism: Pooled analysis of fve prospective general population cohorts. Circulation 2012;126:1964-1971.
20. Cook D, Crowther M, Meade M, et al. Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors. Crit Care Med. 2005;33:1565-1571.
21. Masoomi H, Buchberg B, Reavis KM, Mills SD, Stamos M, Nguyen NT. Factors predictive of venous thromboembolism in bariatric surgery. Am Surg. 2011;77:1403-1406.
22. Dager WE, Kiser TH. Systemic anticoagulation considerations in chronic kidney disease. Adv Chronic Kidney Dis. 2010;17:420-427.
23. Von Visger J, Magee C. Low molecular weight heparins in renal failure. J Nephrol. 2003;16:914-916.
24. Farooq V, Hegarty J, Chandrasekar T, et al. Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease. Am J Kidney Dis. 2004;43:531-537.
25. Hulot JS, Vantelon C, Urien S, et al. Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustment. Ther Drug Monit. 2004;26:305-310.
26. Murphy RX Jr, Alderman A, Gutowski K, et al. Evidence-based practices for thromboembolism prevention: Summary of the ASPS Venous Thromboembolism Task Force Report. Plast Reconstr Surg. 2012;130:168e-175e.
27. Pannucci CJ, Bailey SH, Dreszer G, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2011;212:105-112.
28. Pannucci CJ, Barta RJ, Portschy PR, et al. Assessment of postoperative venous thromboembolism risk in plastic surgery patients using the 2005 and 2010 Caprini Risk score. Plast Reconstr Surg. 2012;130:343-353.
29. Venturi ML, Davison SP, Caprini JA. Prevention of venous thromboembolism in the plastic surgery patient: Current guidelines and recommendations. Aesthet Surg J. 2009;29:421-428.
30. Lovely JK, Nehring SA, Boughey JC, et al. Balancing venous thromboembolism and hematoma after breast surgery. Ann Surg Oncol. 2012;19:3230-3235.
31. Kim EK, Eom JS, Ahn SH, Son BH, Lee TJ. The effcacy of prophylactic low-molecular-weight heparin to prevent pulmonary thromboembolism in immediate breast reconstruction using the TRAM fap. Plast Reconstr Surg. 2009;123:9-12.
32. Lemaine V, McCarthy C, Kaplan K, et al. Venous thrombo-embolism following microsurgical breast reconstruction: An objective analysis in 225 consecutive patients using low-molecular-weight heparin prophylaxis. Plast Reconstr Surg. 2011;127:1399-1406.
33. Gould MK, Garcia DA, Wren SM, et al.; American College of Chest Physicians. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(Suppl):e227S-e277S.
34. Pannucci CJ, Jaber RM, Zumsteg JM, Golgotiu V, Spratke LM, Wilkins EG. Changing practice: Implementation of a venous thromboembolism prophylaxis protocol at an academic medical center. Plast Reconstr Surg. 2011;128: 1085-1092.
35. Ageno W, Agnelli G, Imberti D, et al.; MASTER Investigators. Factors associated with the timing of diagnosis of venous thromboembolism: Results from the MASTER registry. Thromb Res. 2008;121:751-756.
36. Trussler AP, Tabbal GN. Patient safety in plastic surgery. Plast Reconstr Surg. 2012;130:470e-478e.